GraniteShares YieldBOOST Bitcoin ETF (XBTY)

Pretty much

My wife is watching a series on television and called me in to look at one of the episodes. You will not believe what is in this episode. Season 6, Episode 17 of the TV show Elementary, titled "The Worms Crawl In, the Worms Crawl Out," was originally aired on August 20, 2018 on CBS.
In this

That sounds good. Thanks.

MSTX zone under $15, doubled, will add dips

SPX Cycles Update: Possibility of a 60-E-1 7387.00 low due Monday 3rd hour & 2nd UPRO Buy Signal at the close of the 6th hour. Possibility of a D-S-1 (Overdue) 7428.18 low due today at the close.

VVOS........................ACCL........................IONZ...................https://stockcharts.com/sc3/ui/?s=VVOS&p=w&yr=1&mn=3&dy=0&id=p96837884856

SPX Cycles Update: Possibility of a 60-E-1 7387.00 low due Monday 3rd hour & 2nd UPRO Buy Signal at the close of the 6th hour. Possibility of a D-S-1 (Overdue) 7428.18 low due today at the close.

GLP-1 drugs causing “return fatigue” for_retailers:

https://www.wsj.com/business/retail/americans-on-glp-1s-are-overwhelming-retailers-with-their-nonstop-returns-9c512caf America’s apparel companies are fighting increasing returns. The problem is the soaring use of weight-loss drugs.

SOAR.......ACCL........IONZ........EDHL........VVOS...........................https://stockcharts.com/sc3/ui/?s=ACCL&p=w&yr=1&mn=3&dy=0&id=p96837884856

That was apparently not true, as I doubled down at 3 nickels lower. Now I'm out, see yall Monday.

btw...... Rabbit Rukkus has been short S&P for a couple days - keep ferggetin

This will need to be verified, of course. And it’s incomplete with no follow up question about the category selection. Makes no sense given my other recent post on another company’s drug being shot down by CTBVEAG then the company pulls the MAA. And why would CTBVEAG have their verdict under the he

Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing-related sleep disorders and associated chronic health conditions, including obstructive sleep apnea (“OSA”), today announced that it has

Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing-related sleep disorders and associated chronic health conditions, including obstructive sleep apnea (“OSA”), today announced that it has

$BYND ⚡ The Energy Drink Market Is Exploding — And $BYND’s Immerse Wants a Piece of It
The global energy drink industry is in the middle of a historic boom. What started as a niche category dominated by Red Bull has evolved into a $60–80 billion global powerhouse, expanding into fitness, well

$BYND ⚡ The Energy Drink Market Is Exploding — And $BYND’s Immerse Wants a Piece of It
The global energy drink industry is in the middle of a historic boom. What started as a niche category dominated by Red Bull has evolved into a $60–80 billion global powerhouse, expanding into fitness, well

Been waiting for this to dip under $5, but I’m still a tentative buyer. Nasdaq is taking a beating today..

Im getting to the point where that may need to be the case.

viking------curious, have you ever uncovered who the current owner of the purple pansy is ? thanks in advance.

the main unanswered/unknown question is what recommendation or advice the CHM ultimately gave on November 28, 2025.

The only thing we know for sure is that they did not recommend approval.

They either asked for more information, yet again (most likely) - or they recomm

And it's at a 6 month low and down about 80% since then. yikes...
DTREF about to go sub 0.10..? Whodathunkit?

Green light on science (11/28/2025), imo. Probably agreed with MHRA this can’t monopolize UK leukapheresis.

NWBO went from emphasizing increasing capacity with a hybrid c level clean room, to instead pausing initiation of physical construction and then leukapheresis room building, s

Yeah and the tooth fairy still exists. We all know nobody cheats because of rules that are never enforced.